Ethan Rubinstein
Overview
Explore the profile of Ethan Rubinstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
3278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Head B, Rubinstein E, Meyers A
BMC Infect Dis
. 2016 Nov;
16(1):621.
PMID: 27809794
Background: Bacillus anthracis, the causative agent of anthrax, is a spore forming and toxin producing rod-shaped bacterium that is classified as a category A bioterror agent. This pathogenic microbe can...
2.
Head B, Alfa M, Sitar D, Rubinstein E, Meyers A
J Antimicrob Chemother
. 2016 Nov;
72(2):417-420.
PMID: 27798209
Background: Owing to its ability to form spores and toxins, Bacillus anthracis is considered a bioterror agent. Although current therapeutic strategies can be effective, treatment does not prevent sporulation and...
3.
Zhanel G, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, et al.
Drugs
. 2015 Feb;
75(3):253-70.
PMID: 25673021
Tedizolid phosphate is a novel oxazolidinone prodrug (converted to the active form tedizolid by phosphatases in vivo) that has been developed and recently approved (June 2014) by the United States...
4.
Corey G, Rubinstein E, Stryjewski M, Bassetti M, Barriere S
Clin Infect Dis
. 2014 Dec;
60(5):787-96.
PMID: 25472944
Staphylococcus aureus bacteremia (SAB) is one of the most common serious bacterial infections and the most frequent invasive infection due to methicillin-resistant S. aureus (MRSA). Treatment is challenging, particularly for...
5.
Rubinstein E, Keynan Y
Front Public Health
. 2014 Nov;
2:217.
PMID: 25401098
Vancomycin is one of the older antibiotics that has been now in clinical use close to 60 years. Earlier on, vancomycin was associated with many side effects including vestibular and...
6.
Wong D, Aoki F, Rubinstein E
Can J Infect Dis Med Microbiol
. 2014 Nov;
25(5):e85-6.
PMID: 25371694
Eggerthella lenta is an anaerobic, Gram-positive bacillus commonly found in the human digestive tract. Occasionally, it can cause life-threatening infections. Bacteremia due to this organism is always clinically significant and...
7.
Schneeberg A, Bettinger J, McNeil S, Ward B, Dionne M, Cooper C, et al.
BMC Public Health
. 2014 Jun;
14:442.
PMID: 24884433
Background: Fewer Canadian seniors are vaccinated against pneumococcal disease than receive the influenza vaccine annually. Improved understanding of factors influencing pneumococcal vaccination among older adults is needed to improve vaccine...
8.
Rubinstein E, Stryjewski M, Barriere S
Infect Drug Resist
. 2014 May;
7:129-35.
PMID: 24876786
Background: Hospital-acquired pneumonia (HAP) is the most common health care-associated infection contributing to death. Studies have indicated that there may be differences in the causative pathogens and outcomes of ventilator-associated...
9.
Barriere S, Stryjewski M, Corey G, Genter F, Rubinstein E
BMC Infect Dis
. 2014 Apr;
14:183.
PMID: 24708675
Background: Existing data are not consistently supportive of improved clinical outcome when vancomycin dosing regimens aimed at achieving target trough levels are used. A retrospective, post hoc, subgroup analysis of...
10.
Hendricks K, Wright M, Shadomy S, Bradley J, Morrow M, Pavia A, et al.
Emerg Infect Dis
. 2014 Jan;
20(2).
PMID: 24447897
The Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and treatment. The panels included civilian and military anthrax...